Ontario at BIO-Europe 2026 | Source From Ontario

Ontario is taking life sciences to the next level, tackling some of the biggest health related challenges worldwide. Join us at BIO-Europe 2026, Europe's largest partnering conference serving the global biotech industry, to connect with top tier suppliers making the highest medical quality products and services.

To inquire and connect about B2B, networking, and event details please contact Patricia Cosgrove.

Your life sciences partner

The same innovative spirit that led to the discovery of insulin in Ontario one hundred years ago has led to game-changing technologies such as 3D bioprinters and techniques to boost stem cell renewal. With over 49 incubators and accelerators across the province, we are building a life sciences sector fueled by innovation, collaboration, and a pipeline of world-class talent. Discover how Ontario’s life sciences sector is innovating for the future.

Participants

25 in total

20/20 OptimEyes Technologies is developing OPT-101, a sustained-release glaucoma eye drop designed to reduce…
APS Pharma™ is a Canadian innovation-focused specialty chemistry…
AlloWide Health is an Ontario-based biotechnology company developing innovative solutions to improve the…
Altis Labs is the AI endpoint company accelerating clinical trials. Altis has trained proprietary…
Lumerate’s investor intelligence brand, tracks global life science deal flow to reveal behavioral signals that…
BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care. BioScript…
Bough Bio is a pre-clinical stage company focused on decoding the molecular biology of senescent cells to unlock…
Dalriada is a Canadian small molecule discovery company focusing on unlocking challenging and undruggable targets…
Drug formulation has the power to transform promising compounds into life-saving therapies, yet this step is…
JN Nova Pharma is a Canadian biotechnology company developing a proprietary platform technology to…
Over 30% of organ transplant patients have complications due to CMV. Kanata…
Medicenna Therapeutics is a clinical-stage immunotherapy company engineering next-generation cytokine therapies…
Pattern’s patented PPI-100 activates innate immunity against cancers…
PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty…
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
Q&C Services is Canada’s largest independent full-service consultant and importer for pharmaceutical, natural…
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS…
Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation…
Singularity Pharma is a drug discovery business developing novel therapeutics for…
Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class…
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number…
TheraVac Biologics is a late-stage preclinical company developing innovative immunotherapies for…
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide…
Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the…
YYZ Pharmatech Inc. (YYZ) is a deep tech company endeavoring to profoundly progress new medicine for…